Financial Statements [1998/Q4]



The financial statements included herein are unaudited. In the opinion of the management of the Trust, the accompanying financial statements present fairly, subject to normal year-end adjustments, the net claimants’ equity as of September 30, 1998 and 1997 and the changes in net claimants’equity and cash flows for the three months and nine months ended September 30, 1998 presented on the special-purpose basis of accounting described in Note 2, which accounting methods have been applied on a consistent basis.

Mark E. Lederer
Chief Financial Officer

AS OF DECEMBER 31, 1998 AND 1997



                Cash equivalents and investments (Notes 1 & 2)
                         Available-for-sale non-JM
                                     Restricted (Note 8) $49,426,235 $50,362,626
                                     Unrestricted non-JM 970,250,888 934,355,029
                                                   Total 1,019,677,123 984,717,655
                         Other available-for-sale
                                     JM common stock 2,053,489,371 1,293,304,044
                         Held-to-maturity securities
                                     Trust Second Bond 26,852,366 23,992,611
Total cash equivalents and investments 3,100,018,860 2,301,014,310
                Accrued interest and dividend receivables 16,928,255 13,426,713
                Deposits and other assets 284,699 117,340
Total assets 3,117,231,814 2,315,558,363
                Accrued expenses 3,785,711 2,443,354
                Unpaid claims (Note 4, 6 & Exh. III)
                         Settled Pre-Class Action complaint 2,429,040 2,777,876
                         Outstanding Offers – Post Class Action complaint 52,907,100 36,933,108
                Contribution and indemnity claims payable
                         (Notes 4, 8 and Exh. III) 8,397,490 18,496,595
                Lease commitments payable (Note 5) 3,143,884 3,592,053
Total liabilities 70,663,225 64,242,986
NET CLAIMANTS’ EQUITY (Note 6) $3,046,568,589 $2,251,315,377

The accompanying notes are an integral part of these statements.


          BEGINNING OF PERIOD $2,251,315,377 $2,333,106,272
          JM dividend 25,129,422 17,993,795
          Trust Second Bond accretion 2,859,755 2,555,194
          Non-JM investment income (Exh. I) 59,153,999 52,916,891
          Unrealized net gains (losses) on non-JM available-for-sale
                    securities 38,971,098 22,726,555
          Reduction in outstanding claim offers 56,833,341
          Decrease in lease commitments payable 448,169
           Unrealized appreciation in carrying value of JM stock 760,185,327
          Realized gain on  sale of JM stock (notes 1 and 2) 46,800,000
Total additions 933,547,770 153,025,776
          Operating and dispute resolution expenses (Exh. II) 11,513,163 9,857,864
          Management expenses for investments in JM 767,528 661,585
          Net increase in outstanding claim offers 15,973,992
          Claims settled 107,720,861 148,272,665
           Unrealized depreciation in carrying value of JM stock 72,296,500
          Net increase in lease commitments payable 2,583,911
         Contribution and indemnity claims settled 2,319,014 1,144,146
Total deductions 138,294,558 234,816,671
          END OF PERIOD $3,046,568,589 $2,251,315,377

The accompanying notes are an integral part of these statements.


1998 1997
          JM dividends $22,774,879 $16,708,524
          Investment receipts 58,388,231 54,634,691
          Proceeds from sale of JM common  stock 46,800,000
          Investment receipts on escrow accounts (Note 8) 182,348 305,008
Total cash inflows 128,145,458 71,648,223
          Claim payments made 108,069,697 148,430,352
          Contribution and indemnity claim payments 12,600,467 9,719,182
Total cash claim payments 120,670,164 158,149,534
          Disbursements for Trust operating, dispute resolution,
                    and asset management 11,319,565 10,892,768
Total cash outflows 131,989,729 169,042,302
NET CASH OUTFLOWS (3,844,271) (97,394,079)
          Net unrealized gains (losses) on non-JM securities
                    available-for-sale 38,971,098 22,726,555
          Change in deposits and other assets (167,359) 80,162
          NON-JM INVESTMENTS AVAILABLE-FOR-SALE 34,959,468 (74,587,362)
          AVAILABLE-FOR-SALE, BEGINNING OF PERIOD 984,717,655 1,059,305,017
          AVAILABLE-FOR-SALE, END OF PERIOD $1,019,677,123 $984,717,655

The accompanying notes are an integral part of these statements.


AS OF DECEMBER 31, 1998 AND 1997



The Manville Personal Injury Settlement Trust (the Trust), organized pursuant to the laws of the state of New York with its office in Fairfax, Virginia, was established pursuant to the Manville Corporation (Manville) Second Amended and Restated Plan of Reorganization (the Plan). The Trust was formed to assume Manville’s liabilities resulting from pending and potential litigation involving (i) individuals exposed to asbestos who have manifested asbestos-related diseases or conditions, (ii) individuals exposed to asbestos who have not yet manifested asbestos-related diseases or conditions and (iii) third-party asbestos-related claims against Manville for indemnification or contribution. Upon consummation of the Plan, the Trust assumed liability for existing and future asbestos health claims. The Trust had initial funding and will receive ongoing fixed and contingent funding as described below under “Funding of the Trust.” The Trust’s funding is dedicated solely to the settlement of asbestos health claims and the related costs thereto, as defined in the Plan. The Trust was consummated on November 28, 1988.

In December 1998 the Trust formed a wholly-owned corporation, the Claims Resolution Management Corporation (CRMC), to provide the Trust claim processing and settlement services.  CRMC began operations on January 1, 1999 in Fairfax, Virgnia and the Trust’s office is now in Katonah, New York.

Funding of the Trust

The Trust was initially funded from the following sources:

  • Manville provided $150 million in cash plus $5.4 million in accrued interest. At consummation, the Trust was required to transfer approximately $27.5 million to the Manville Property Damage Settlement Trust (PD Trust).
  • Insurance settlement proceeds totaling $695 million, which included $72 million in interest thereon.
  • 24,000,000 shares of Manville Common Stock (50% of Manville Common Stock outstanding at consummation).
  • 7,200,000 shares of a new Series A Convertible Preferred Stock of Manville. In December 1992, these shares were converted into 72,000,000 shares of Manville Common Stock.
  • A $50 million interest-bearing note receivable (the Trust Note) payable in equal installments in 1990 and 1991. In December 1989, Manville prepaid the Trust Note. The payment included the $50 million in principal and $8.1 million in accrued interest.
  • Up to $1.65 billion pursuant to the terms of a bond (the Trust Bond). The Trust Bond initially provided for semi-annual installments of $37.5 million commencing in 1991 and ending in 2012. In 1994, the Trust Bond was prepaid by Manville.
  • Up to $150 million pursuant to the terms of a second bond (the Trust Second Bond). The Trust Second Bond requires Manville to pay the Trust $37.5 million semi-annually in the years 2013 and 2014. Amounts payable by Manville under the Trust Second Bond may be deferred to the extent that funds are not required for settlement of liquidated asbestos health claims, with all such deferred amounts payable in the event of need. The Trust Second Bond bears no interest during its term.
  • Up to 20% of Manville’s profits as defined in the Plan, payable beginning in 1992 with respect to the prior year’s profits (the Profit Sharing Rights). In April 1996, the Profit Sharing Rights were exchanged for an additional 32,527,110 shares of Manville Common Stock.

Manville Stock Interests

In March 1996, Manville changed its name to Schuller Corporation (Schuller).   In May 1997, Schuller changed its name to Johns Manville Corporation (JM). On April 13, 1998 JM purchased 3.6 million shares of its common stock from the Trust at $13 per share, the average of the closing prices between March 12 and April 8, 1998. The Trust received $46.8 million from the sale of the JM common stock. After giving effect to the transaction, the Trust owns 124,927,110 shares of JM common stock or approximately 79% of outstanding shares.


(a) Basis of Presentation

The Trust’s financial statements are prepared using special-purpose accounting methods that differ from generally accepted accounting principles (GAAP). The special-purpose accounting methods were adopted in order to better communicate to the beneficiaries of the Trust the amount of equity available for payment of current and future claims. These special-purpose accounting methods are enumerated as follows:

  1. The financial statements are prepared using the accrual basis of accounting.
  2. The funding received from JM and its liability insurers has been recorded directly to net claimants’ equity. These funds do not represent income of the Trust. Settlement offers for asbestos health claims are reported as deductions in net claimants’ equity and do not represent expenses of the Trust.
  3. Costs of non-income producing assets, which will be exhausted during the life of the Trust and are not available for satisfying claims, are expensed as they are incurred. These costs include acquisition costs of computer hardware, software, software development, office furniture and leasehold improvements.
  4. Future fixed liabilities and contractual obligations entered into by the Trust are recorded directly against net claimants’ equity. Accordingly, the future minimum rental commitments outstanding at period end for non-cancelable operating leases, net of any sublease agreements, have been recorded as deductions to net claimants’ equity.
  5. The liability for unpaid claims reflected in the statements of net claimants’ equity represents settled but unpaid claims and outstanding settlement offers. Post-Class Action complaint claims’ liability is recorded once a settlement offer is made to the claimant (Note 4) at the amount equal to the expected pro rata payment. No liability is recorded for future claim filings and filed claims on which no settlement offer has been made. Net claimants’ equity represents funding available to pay present and future claims on which no fixed liability has been recorded.
  6. Available-for-sale securities are recorded at market. Held-to-maturity securities are recorded at amortized cost. All interest and dividend income, as well as net realized gains/losses, on non-JM available-for-sale securities are included in non-JM investment income on the statements of changes in net claimants’ equity. Net unrealized gains/losses are recorded as a separate component on the statements of changes in net claimants’ equity.

The preparation of financial statements in conformity with the special-purpose accounting methods described above requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of additions and deductions to net claimants’ equity during the reporting period. Actual results could differ from those estimates. The most significant estimates with regard to these financial statements relates to unpaid claims, as discussed in Notes 4 and 6.

(b) JM Common Stock Interest

The Trust’s stock interests represent a majority stock interest in JM. The accounts of JM have not been consolidated in the accompanying financial statements because: (i) JM stock interests are held by the Trust in order to pay asbestos health claims, and as such, the investment is likely to be temporary; and (ii) the objective of the financial statements is to communicate the equity available over the life of the Trust to current and future claimants. Thus, the Trust believes that recording these stock interests at current market value is appropriate.

At consummation, the Trust’s stock interests were recorded at market value. Subsequent changes in their market values are shown separately as changes in the carrying value of JM common stock in the statements of changes in net claimants’ equity. The market value of the JM Common Stock held by the Trust is recorded by using the closing price of JM Common Stock on the New York Stock Exchange on the last day of the appropriate reporting period. As of December 31, 1998 and 1997, that price was $16 7/16 and $10 1/16 per share, respectively. Nevertheless, the Trust may not realize this value as a result of potential illiquidity in the public sale of a major position in JM Common Stock without disruption to the public market. Further, any premium that might be obtained upon a private sale of a controlling interest in JM may also impact this value.

(c) Trust Second Bond

The Trust Second Bond is reported using a discount rate of 11.75% as agreed upon in the Bond Repurchase Agreement dated September 22, 1994 between the Trust and JM. The discount rate has not been adjusted to reflect current interest rates or other market conditions since its market value is not readily ascertainable.

(d) Cash Equivalents and Non-JM Investments

In 1997 the Trust adopted a new investment policy which provided for greater diversification of the Trust’s investment holdings. At September 30, 1998 the Trust has recorded all its non-JM investment securities at market value. At December 31, 1998 and 1997 the Trust has recorded all its non-JM investments securities at market value, as follows:

                                                                       1998                                             1997         
     Cost     Market      Cost     Market
   Cash equivalents $4,230,723 $ 4,230,723 $28,751,391 $28,688,190
   U.S. Govt. oblig. 13,331,154 13,402,996   19,238,918   19,286,792
   Corporate and other debts   3,526,663    3,551,938     2,372,317     2,387,644
   Equities – U.S. 24,600,836  28,240,578
Total $45,689,376 $49,426,235 $50,362,626 $50,362,626


   Cash equivalents $98,051,017 $ 98,051,017 $453,722,155    $453,780,943
   U.S. govt. obligations 499,158,265   503,279,803   234,284,344      235,206,124
   Foreign govt. obligations   99,366,158   102,204,285     80,345,944        81,891,527
   Corporate and other debt   72,589,830     73,162,639       8,953,358           8,952,912
   Equities – U.S.   86,407,257   126,034,423     82,882,826      101,417,518
   Equities – International   56,717,568     67,518,721     51,439,847        53,106,005
Total $912,290,095 $970,250,888 $911,628,474    $934,355,029

The maturities of the Trust’s non-JM available-for-sale securities at market value (excluding cash equivalents) are as follows:

Less Than
1 Year
After 1 Year
Through 5 Years
After 5 Years
Through 10 years
After 10 Yrs
U.S. govt. obligations $291,322,751 $101,962,473 $    2,843,665 $120,553,910
Foreign govt. obligations     17,183,085     13,314,973     63,971,939       7,734,288
Corporate and other debt                  596      30,556,059     33,416,068     12,741,854
Total $308,506,432 $145,833,505 $100,231,672 $141,030,052

The Trust invests in two types of derivative financial instruments. Equity index futures are used as strategic substitutions to cost effectively replicate the underlying index of its domestic equity investment fund. At December 31, 1998, the fair value of these instruments was approximately $3.0 million and was included in non-JM investments available-for-sale on the statement of net claimants’equity. Foreign currency forwards are utilized for both currency translation purposes and to hedge against the currency risk inherent in foreign bond issues. At December 31, 1998, the Trust held at market value approximately $142.5 million in sell currency forward contracts offset by approximately $144.8 million in buy currency forward contracts. The unrealized losses on these outstanding currency forward contracts of approximately $2.3 million is principally offset by a corresponding unrealized gain due to currency exchange on the underlying securities being hedged. These amounts are recorded in the statement of changes in net claimants’equity at December 31, 1998.

(e) Fixed Assets

The cost of non-income producing assets that will be exhausted during the life of the Trust and are not available for satisfying claims are expensed as incurred. Since inception these costs, net of disposals, include:

            Acquisition of furniture and equipment $   698,649
            Acquisition of computer hardware and software 1,261,622
            Leasehold improvements       42,011
Total $2,002,282

These items have not been recorded as assets, but rather as direct deductions to net claimants’ equity in the accompanying financial statements. The cost of fixed assets, net of proceeds on disposals, that were expensed during the years ended December 31, 1998 and 1997 was approximately $243,800 and $226,600 respectively.

Depreciation expense related to asset acquisitions using generally accepted accounting principles would have been approximately $203,800 and $227,300 for the years ended December 31, 1998 and 1997, respectively.

(f) JM Dividends

Beginning in September 1996, the JM Board of Directors has declared regular quarterly dividends. JM dividends are reported as additions to net claimant’s equity.


During April 1997, the Trust disqualified all of the approximately 27,000 unsettled claims which had been filed by the Maritime Asbestosis Legal Clinic (MALC). At the time of the disqualification, the Trust stated that, among other things, the documentation that had been submitted in support of the MALC claims was inadequate and that the claims lacked both credibility and reliability.

In early June 1997, certain MALC claimants filed two essentially identical civil actions against the Trust and the Trustees alleging breach of fiduciary duties and breach of contract and seeking equitable relief. These actions are now pending in the United States District Court for the Eastern District of New York. The Trust and Trustees contested this matter and filed a third party complaint in connection with the case. During the third quarter of 1998, under the supervision of a Special Master appointed by the court, the parties began negotiations to attempt to settle the litigation. It appears that a settlement will be achieved pursuant to which most of the MALC disqualified claims will be eligible for refiling by MALC pursuant to agreed upon filing procedures. In addition, the Trust has offered to settle all of MALC’s previously categorized eligible pleural disease claims for an amount less than scheduled values, and accordingly, has recorded the liability in Unpaid Claims on the Statements of Net Claimants’ Equity as of December 31, 1998.

In December 1997, the Trust filed a civil action in the United States District Court for the Eastern District of New York against seven tobacco companies to recover reimbursements for all past sums paid by the Trust to individuals whose asbestos disease or illness was caused in whole or in part, or was increased in severity, by the smoking-related illness which the tobacco defendants caused. The defendants have filed answers denying the allegations in the complaint. This case is in the early stages of discovery and it is too early to estimate the amount, if any, of any recovery.

In September 1998, the Trust was sued by certain Maryland claimants who allege that the Trust has violated the terms of the Trust Distribution Process with respect to certain medical audit procedures. The complaint asks the court to order the Trust to cease its medical audit program, requests the immediate payment of certain claims, and also seeks an independent review of certain of the Trust’s financial actions and the dismissal of the Trustees and four Trust staff members. The Trust has filed an answer which denies the allegations of the complaint and has also filed a counterclaim seeking judicial approval of the medical audit program. Seven additional lawsuits concerning the medical audit procedures have been filed by attorneys who allege they represent Trust beneficiaries. In addition, two interventions by Class Action representatives (Note 4) have been filed. It is expected that all of these cases will be consolidated in one proceeding. Issues concerning such consolidation, as well as case management (including discovery), have been assigned to a United States Magistrate. Management believes that this litigation will not materially affect outstanding settlement offers as the Trust does not record a liability until an offer has been made.


The Trust distinguishes between claims that were resolved prior to the filing of the class action complaint on November 19, 1990 and claims resolved after the filing of that complaint. Claims resolved prior to the complaint (Pre-Class Action Claims) were resolved under various payment plans, all of which called for 100% payment of the full liquidated amount without interest over some period of time. However, between July 1990 and February 1995, payments on all claims except qualified exigent health and hardship claims were stayed by the Courts. By Order of the Courts on July 22, 1993 (which became final on January 11, 1994), a plan submitted by the Trust was approved to immediately pay, subject to claimant approval, a discounted amount on Pre-Class Action Claims, in full satisfaction of these claims. The discount amount taken, based on the claimants who accepted the Trust’s discounted offer, was approximately $135 million.

The unpaid liability for the Post-Class Action claims represents outstanding offers made in First-in, First-out (FIFO) order to claimants eligible for settlement after November 19, 1990. Under the TDP (Note 6), claimants receive an initial pro rata payment equal to 10% of the liquidated value of their claim. The Trust remains liable for the unpaid portion of the liquidated amount only to the extent that assets will be available after paying all claimants the established pro rata share of their claims. The Trust makes these offers in the form of a check made payable to the claimant and/or claimant’s counsel. If the offer is accepted, the check is deposited, a Trust release is completed and the claim is recorded as settled. An unpaid claim liability is recorded once an offer is made. The unpaid claim liability remains on the Trust’s books until accepted or expiration of the offer after 180 days. A claimant may request that an offer be extended for an additional 180 days.

Pursuant to the Stipulation of Settlement, the Trust is obligated to pay approximately $63 million plus investment earnings on funds set aside for contribution and indemnity claims occurring before July 25, 1994. To date the Trust has paid approximately $58 million under this obligation.


Operating Leases

In September 1993, the Trust executed a 5-year lease through December 1998 for its offices in Fairfax, Virginia. The lease was extended for an additional 5 years beginning at the expiration of the current lease during 1997.

Future minimum rental commitments under this operating lease, as of December 31, 1998 are as follows:

                               Calendar Year Amount
                                   1999 592,165
                                   2000 609,930
                                   2001 628,228
                                   2002 647,075
                                   2003        666,486
Total $3,143,884

This obligation has been recorded as a liability at face value in the accompanying financial statements.


A class action complaint was filed on behalf of all Trust beneficiaries on November 19, 1990, seeking to restructure the methods by which the Trust administers and pays claims. On July 25, 1994, the parties signed a Stipulation of Settlement which included a revised Trust Distribution Process (the TDP). The TDP prescribes certain procedures for distributing the Trust’s limited assets, including pro rata payments and initial determination of claim value based on scheduled diseases and values. The Court approved the settlement in an order dated January 19, 1995. Though six appeals were filed with the Court of Appeals, no stay was granted and the Trust implemented the TDP payment procedures effective February 21, 1995. On February 21, 1996, the Court of Appeals affirmed the decision.

Prior to the commencement of the class action in 1990, the Trust filed a motion for a determination that its assets constitute a “limited fund” for purposes of Federal Rules of Civil Procedure 23(b)(1)(B). The Courts adopted the findings of the Special Master that the Trust is a “limited fund”. In part, the limited fund finding concludes that there is a substantial probability that estimated future assets of the Trust are and will be insufficient to pay in full all claims that have been and will be asserted against the Trust.

The TDP contains certain procedures for the distribution of the Trust’s limited assets. Under the TDP, the Trust forecasts its anticipated annual sources and uses of cash until the last projected future claim has been paid. A pro rata payment percentage is calculated such that the Trust will have no remaining assets or liabilities after the last future claimant receives his/her pro rata share.

The Trust has conducted its own research and monitored studies prepared by the Courts’ appointee regarding the valuation of Trust assets and liabilities. Based on this valuation, the TDP provides for an initial 10% payment of the liquidated value of current and future claims. Accordingly, the Trust has reported Post-Class Action Claims at 10% of their liquidated value. The 10% pro rata payment represents the Trust’s best estimate of funds available over the life of the Trust to pay claims settled under the TDP. The Trust will continue to monitor this estimate based on changes in settlement practices and changes in future projected values of Trust assets and liabilities and make any necessary changes in the pro rata payment percentage as required under the TDP.


The Trust established a tax-deferred employee savings plan under Section 401 (k) of the Internal Revenue Code, with an effective date of January 1, 1988. The plan allows employees to defer a percentage of their salaries within limits set by the Internal Revenue Code with the Trust matching contributions by employees of up to 6% of their salaries. The total employer contributions and expenses under the plan were approximately $284,200 and $322,100 for the years ended December 31, 1998 and 1997, respectively.


In order to avoid the high costs of director and officer liability insurance and with the approval of the United States Bankruptcy Court for the Southern District of New York, the Trust established a segregated security fund of $30,000,000 and, with the additional approval of the United States District Court for the Southern and Eastern Districts of New York, an escrow fund of $3,000,000 from the assets of the Trust, which are devoted exclusively to securing the obligations of the Trust to indemnify the former and current Trustees and officers, employees, agents and representatives of the Trust. In addition, a $15,000,000 escrow and security fund was established to secure the obligations of the Trust to exclusively indemnify the current Trustees, whose access to the other security funds is subordinated to the former Trustees. Upon the final order in the Class Action litigation (Note 4), the $15,000,000 escrow and security fund was reduced by $5,000,000. Pursuant to Section 5.07 of the plan, Trustees are entitled to a lien on the segregated security and escrow funds to secure the payment of any amounts payable to them through such indemnification. Accordingly, in total $43 million has been transferred from the Trust’s bank accounts to separate escrow accounts and pledge and security agreements have been executed perfecting those interests. The investment earnings on these escrow accounts accrue to the benefit of the Trust and are recorded as unrestricted investments.

Pursuant to the Stipulation of Settlement, the Trust funded separate investment accounts for two of the sub-class beneficiaries. During 1996, one of these accounts was fully disbursed and the remaining balance for the other account at December 31, 1998 is $6.4 million. This balance and the $43 million of self-insurance funds described above, have been reported as restricted investments.


For Federal income tax purposes, JM has elected for the qualified assets of the Trust to be taxed as a “Designated Settlement Fund.” Income and expenses associated with these qualified assets of the Trust are taxed in accordance with Section 468B of the Internal Revenue Code. JM is obligated to indemnify the Trust for any income tax liability imposed upon the Trust.

To the extent that JM has a residual interest in any assets of the Trust or such assets represent stock or indebtedness of JM, the income and expenses attributable to such assets are taxed as if these assets were in a “Grantor Trust.” In addition, for tax purposes the Trust has segregated at times certain non-JM available-for-sale securities that are held in a Grantor Trust Account. Consequently, income and expenses associated with these assets are included in the income tax return of JM (the Grantor) and are not part of the Designated Settlement Fund.


Proof of claim forms have been filed with the Trust as follows:

         As of
          As of
Claims filed      396,134         366,001
Voided claims (1)      (13,497)           (9,328)
Currently disqualified (2)      (27,488)         (29,451)
Expired offers (3)      (27,240)         (23,342)
            Active claims      327,909          303,880
Settled claims   (193,949)       (168,710)
Claims currently eligible for settlement      133,960         135,170

(1) Claim filings that are permanently ineligible due to duplication of filing, withdrawal or missing critical information.

(2) Claim filings on hold until representation or content problems are resolved. (Note 3)

(3) Claims that received a Trust offer, but failed to respond within the offer acceptance period.
A claim may be reactivated upon written request and is eligible for a new offer at the end of
the FIFO queue.


The Trust and JM announced on January 25, 1999 that they will undertake a review of strategic alternatives available to maximize JM’s shareholder value. Such alternatives include the possible sale or merger of JM. No decision has been made to enter into any transaction or as to what form the transaction might take.

The following exhibits are provided in accordance with Article 3.02 (d) (iii) of the Manville Personal Injury Settlement Trust Agreement.


Exhibit I   Non-JM Investment Income for the Years Ended December 31, 1998
and 1997

Exhibit II  Operating and Dispute Resolution Expenses for the Years Ended
December 31, 1998 and 1997

Exhibit III, Page 1 – Schedule of Liquidated Claims Since Consummation (November 28,
1988) Through december 31, 1998

Exhibit III, Page 2 – Page 2 – Schedule of Liquidated Claims for the Year Ended
December 31, 1998

                                                                                                                                   EXHIBIT I




         Interest $47,479,235 $49,231,300
         Dividends 3,036,582 2,500,764
         Net realized gains 10,407,992 2,333,984
                     Total non-JM investment income 60,923,809 54,066,048
          Investment expenses (1,769,810) (1,149,157)
TOTAL $59,153,999 $52,916,891

The accompanying notes are an integral part of this exhibit.

                                                                                                                                        EXHIBIT II



        Personnel costs $6,470,098 $6,210,885
      Office general and administrative 1,161,626 1,250,929
      Travel and meetings 218,225 138,251
      Board of Trustees 386,417 348,157
      Professional fees 2,891,347 1,602,646
      Net fixed asset purchases 243,818 226,632
      Computer and other EDP costs 83,689 54,904
 Total operating expenses 11,455,220 9,832,404
           (1)    Certain 1997 expenses have been reclassified to be consistent with 1998 reporting.
      Litigation defense 41,993 22,247
      Arbitration 15,950 3,213
          Total dispute resolution expenses 57,943 25,460
                 TOTAL $11,513,163 $9,857,864


The accompanying notes are an integral part of this exhibit.

                                                                                                 EXHIBIT III, Page 1 of 2                                                                                                           



Payment Amount
Trust Liquidated Claims
     Pre-Class Action Complaint
             November 19, 1990 and Before-
     Liquidated Claim Value 27,612 $1,188,382,855
     Present Value Discount (1)      ($134,990,193)
     Net Settlements 27,612 $1,053,392,662
     Payments (27,444) ($1,051,270,144)     $38,306
     Unpaid Balance 168 $2,122,518
     Post-Class Action Complaint
               After November 19, 1990-
     Offers Made at Full Liquidated Amount 183,403 $8,567,894,200
     Reduction in Claim Value (2) ________ ($7,710,826,815)
     Net Offer Amount 183,403 857,067,385
     Payments (166,337) (804,160,285)      $4,835
     Offers Outstanding 17,066 $52,907,100
Manville Liquidated Claims (3)
     Liquidated Claim Value 174 $25,253,142
     Payments (158) (24,946,620)
     Unpaid Balance 16 $306,522
Co-Defendant Liquidated Claims (4)
     Liquidated Claim Value $84,069,552
     Investment Receipts (5) 2,308,584
     Payments (77,980,646)
     Unpaid Balance $8,397,490

1)    The unpaid liability for Pre-Class Action Complaint claims has been reduced based upon a plan approved by the Courts in
January, 1994 which requires the Trust to offer to pay a discounted amount in full satisfaction of the unpaid  claim amount.

(2)   Under the TDP, Post Class Action Complaint claims have been reported at 10% of their liquidated value.

(3)    Manville Liquidated Claims refers to Liquidated AH Claims (as defined in the Plan) which the Trust has paid or accrued as
payable pursuant to an order of the United States Bankruptcy Court  for the Southern District of New York dated January 27, 1987.

(4)    Number of personal injury claimants not identifiable.

(5)    Investment receipts of separate investment escrow account established for the sub-class beneficiaries per the Stipulation of
Settlement, net of income taxes.

                                              The accompanying notes are an integral part of this exhibit.

                                                                                            EXHIBIT III , Page 2 of  2



Payment Amount
Trust Liquidated Claims
     Pre-Class Action Complaint
             November 19, 1990 and Before-
             Payable as of December 31, 1997 170 $2,471,354
             Net adjustments 1 (10,638)
            Paid (1) (3) (338,198)
             Payable as of December 31, 1998 168 $2,122,518
     Post-Class Action Complaint
             After November 19, 1990- (2)
             Offers Outstanding as of December 31, 1997 9,632 $36,933,108
             Net Offers Made (3) 32,672 123,705,491
             Offers Accepted/Paid (25,238) (107,731,499) $4,269
             Offers Outstanding as of December 31, 1998 17,066 $52,907,100
Manville Liquidated Claims
             Payable as of December 31, 1997 16 $306,522
             Payable as of December 31, 1998 16 $306,522
Co-Defendant Liquidated Claims (4)
             Payable as of December 31, 1997 $18,496,595
             Settled 2,319,014
             Investment Receipts (5) 182,348
             Paid (12,600,467)
             Payable as of December 31, 1998 $8,397,490

(1)    During the period the dollar amount of paid claims includes fully and partially paid claims. The number of paid claims
represents only fully paid claims.

(2)    Under the TDP, Post Class Action Complaint claims have been reported at 10% of their liquidated value.

(3)    Represents payment offers made during the period net of rejected and expired offers.

(4)    Number of personal injury claimants not identifiable.

(5)    Investment receipts of separate investment escrow account established for the sub-class beneficiaries per the
stipulation of settlement, net of income taxes.